Bernadette Redd
7PUBLICATIONS
41CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 17, 2026
Durvalumab and cediranib with and without olaparib in recurrent ovarian cancer: a phase II proof-of-concept study.Junya Tabata, Tzu-Ting Huang, Elena Giudice
|Nov 19, 2025
Phase II proof-of-concept study of durvalumab and cediranib with and without olaparib in recurrent ovarian cancer.Jung-Min Lee, Junya Tabata, Tzu-Ting Huang
|Jul 02, 2024
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors.Andrea B Apolo, Daniel M Girardi, Scot A Niglio
|Mar 30, 2024
The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial.Elena Giudice, Tzu-Ting Huang, Jayakumar R Nair
|Oct 23, 2023
Author Correction: Defining features of hereditary lobular breast cancer due to CDH1 with magnetic resonance imaging and tumor characteristics.Lauren A Gamble, Paul H McClelland, Martha E Teke
|Sep 27, 2023
Defining features of hereditary lobular breast cancer due to CDH1 with magnetic resonance imaging and tumor characteristics.Lauren A Gamble, Paul H McClelland, Martha E Teke
Pageof 2
Frequent Collaborators
4 joint publications
Nahoko Sato
3 joint publications
Shraddha Rastogi
3 joint publications
Elena Giudice
3 joint publications
Sunmin Lee
3 joint publications
Tzu-Ting Huang
2 joint publications
Amir Mortazavi
2 joint publications
Rosa Nadal
2 joint publications
Donald P Bottaro
2 joint publications
William D Figg
2 joint publications
Elad Sharon
